Benefits of 1000 bottles of red wine could come from pill

   Feb 5, 11:57 am

Washington, Feb 5 (ANI): Lovers of red wine were delighted when it was found to contain resveratrol - a compound supposed to improve health and maybe even lengthen life.

But studies have insisted that to see benefits, you would need to consume large amounts of the compound - more than is found in a bottle of wine.

Now a new study suggests we could get the equivalent of large resveratrol doses from pills we already have- a class of drugs that are being tested for use as treatments for Alzheimer's and Parkinson's disease.

The findings suggest these drugs, known as known as phosphodiesterase type 4 (PDE4) inhibitors, may provide a practical way to reap red wine's benefits than consuming buckets of the stuff (which would certainly carry health risks).

"[The study] reveals a novel utility for this class of drugs that hasn't been explored before," said study researcher Dr. Jay H. Chung, chief of the Laboratory of Obesity and Aging Research at the National Heart, Lung, and Blood Institute.

However, the study was conducted in mice, and the results will need to be replicated in people.

In the study, scientists aimed to figure out exactly how resveratrol, a compound in red wine, acts inside cells. They discovered resveratrol works in a different manner than previously thought.

The study showed that resveratrol inhibits a protein known as phosphodiesterase type 4 (PDE4). That meant that resveratrol is a PDE4 inhibitor.

Knowing that drugs called PDE4 inhibitors werebeing tested to treat Alzheimer's, the researchers gave one such drug, called rolipram, to mice.

They found the drug produced all the health benefits of resveratrol, including preventing diet-induced obesity and improving control over blood sugar levels.

In studies on people, resveratrol has been shown to have anti-diabetes effects. But people would need to consume about 1,000 bottles of red wine a day in order to take in enough resveratrol to see true health benefits, Chung said.

PDE4 inhibitors could provide a realistic way for people to get the same benefits, the researchers said. In addition, PDE4 inhibitors may be less toxic than resveratrol itself, because the compound interacts with many proteins inside cells.

"By just targeting the key player [PDE4] you minimize the potential for adverse effects," Chung added.

Chung said he is planning to conduct a follow-up study that examines the effects of rolipram on obese people with insulin resistant.

The study has been published in the journal Cell. (ANI)

'Severely infectious' bacterial strain can survive in contact lens solution Apr 17, 1:30 pm
Washington, April 17 (ANI): Scientists have found a bacterial strain that is associated with more severe infections and survives longer in contact lens disinfectant solution.
Full Story
BMI linked to postmenopausal breast cancer regardless of body shape Apr 17, 11:40 am
Washington, April 17 (ANI): A new study has revealed that Body Mass Index associated with breast cancer, regardless of body shape.
Full Story
TV smoking triggers adult tobacco use Apr 17, 10:59 am
Washington, Apr 17 (ANI): A new study suggests that even though smoking appears far less frequently in US television shows than it used to, its portrayal may still be triggering the urge in adult smokers.
Full Story
Cheap 'magic' polypill helps fight heart diseases Apr 16, 12:01 pm
London, April 16 (ANI): Scientists have revealed that a polypill that is packed with aspirin, a statin and a blood-pressure drug can help fight heart diseases.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY